Showing 1130 – 1140 of 1304 results
-
Klaviyo Inc Initiation
William Blair initiated research coverage of Klaviyo, Inc. (KVYO $32.89), a full stack marketing automation platform with robust data management and segmentation capabilities that largely serves SMB and midmarket retail businesses today.
-
Celsius Holdings Inc Initiation
William Blair initiated research coverage of Celsius Holdings, Inc. (CELH $162.02), a high-growth company that develops, processes, markets, sells, and distributes functional energy drinks and liquid supplements in the United States and abroad.
-
Cabaletta Bio Inc Initiation
William Blair initiated research coverage of Cabaletta Bio, Inc. (CABA $13.69), a clinical-stage company focused on the development and commercialization of first-in-class immune cell therapies for the treatment of severe autoimmune disorders.
-
PROCEPT BioRobotics Corporation Initiation
William Blair initiated research coverage of PROCEPT BioRobotics Corporation (PRCT $31.85), a medical device company focused on creating urology solutions such as the minimally invasive image-guided AquaBeam Robotic System.
-
Qualys Inc Initiation
William Blair initiated research coverage of Qualys, Inc. (QLYS $126.80), a leading provider of cloud-based cybersecurity and compliance solutions that help companies identify security risks, maintain compliance with industry standards, and remediate security vulnerabilities.
-
Warby Parker Inc Initiation
William Blair initiated research coverage of Warby Parker, Inc. (WRBY $11.19), an omnichannel retailer of prescription glasses, contact lenses, and sunglasses across the United States and Canada.
-
Cell Therapy and Autoimmune Disorders
Equity research analysts Sami Corwin and Matt Phipps provide an overview of the known biological underpinnings of autoimmunity and the rationale for using chimeric antigen receptor T cells (CAR-Ts) to potentially treat millions who suffer from autoimmune diseases.
-
Sovos Brands Inc Initiation
William Blair initiated research coverage of Sovos Brands, Inc. (SOVO $14.18). Sovos is a growing food company that innovates and markets disruptive and differentiated brands, including Rao’s, Noosa, Birch Benders, and Michael Angelo’s. It products are premium and convenient and sold in all major classes of retail trade.
-
Pyxis Oncology Inc Initiation
William Blair initiated research coverage of Pyxis Oncology, Inc. (PYXS $13.30), a preclinical-stage company focused on the development of antibody-drug conjugates (ADCs) and immuno-oncology antibodies for the treatment of cancer.
-
Cellebrite DI Ltd Initiation
William Blair initiated research coverage of Cellebrite DI Ltd. (CLBT $10.71), the worldwide leader in smartphone forensics with its UFED software.